TMC Life Sciences Berhad First Quarter 2025 Earnings: EPS: RM0.002 (vs RM0.009 in 1Q 2024)

Simply Wall St

November 21, 2024

TMC Life Sciences Berhad (KLSE:TMCLIFE) First Quarter 2025 Results

Key Financial Results

Revenue: RM82.8m (down 10% from 1Q 2024).
Net income: RM2.94m (down 81% from 1Q 2024).
Profit margin: 3.5% (down from 16% in 1Q 2024). The decrease in margin was primarily driven by lower revenue.
EPS: RM0.002 (down from RM0.009 in 1Q 2024).

earnings-and-revenue-history — KLSE:TMCLIFE Earnings and Revenue History November 21st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

TMC Life Sciences Berhad shares are down 3.8% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 2 warning signs for TMC Life Sciences Berhad you should be aware of.

If you're looking to trade TMC Life Sciences Berhad, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Valuation is complex, but we're here to simplify it.

Discover if TMC Life Sciences Berhad might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.